Author:
Ventura-López Claudia,Cervantes-Luevano Karla,Aguirre-Sánchez Janet S.,Flores-Caballero Juan C.,Alvarez-Delgado Carolina,Bernaldez-Sarabia Johanna,Sánchez-Campos Noemí,Lugo-Sánchez Laura A.,Rodríguez-Vázquez Ileana C.,Sander-Padilla Jose G.,Romero-Antonio Yulia,Arguedas-Núñez María M.,González-Canudas Jorge,Licea-Navarro Alexei F.
Funder
Centro de Investigación Científica y de Educación Superior de Ensenada, Baja California
Subject
Pharmacology,General Medicine
Reference37 articles.
1. World Health Organization, Coronavirus disease situation, 2022. 〈https://covid19.who.int/〉, (Accessed 27 April 2022).
2. Human coronavirus: host-pathogen interaction;Fung;Annu. Rev. Microbiol.,2019
3. Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity;Ford;Biochem. J.,2015
4. National Library of Medicine (U.S.), Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 Diabetes (COMET), Identifier NCT01386671, 2018. Available from: 〈https://clinicaltrials.gov/ct2/show/study/NCT01386671〉.
5. 146-LB: efficacy and safety of metformin glycinate vs. metformin hydrochloride in metabolic control and inflammatory mediators in Type 2 diabetes mellitus patients (T2DM);González-Canudas;ADA,2019
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献